Skip to main content

Find Clinical Trials

Home
Conditions
Metastatic Melanoma

Clinical trial condition

Metastatic Melanoma

Explore clinical trials studying Metastatic Melanoma. Study availability and eligibility vary by location and protocol.

228 public trials 41 recruiting studies

Refine in advanced search Browse all conditions

Metastatic Melanoma trial results

Recruiting

Immunotherapy Efficacy and PD-L1 as a Predictive Biomarker in Metastatic Melanoma in Slovenia

NCT07422779

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +11 more
Locations: Institute of Oncology Ljubljana Ljubljana, Slovenia

View Trial Details

Recruiting

Efficacy of First-Line Immunotherapy in Metastatic Melanoma in Slovenia and Identification of Predictive Biomarkers

NCT07407166

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: Institute of Oncology Ljubljana Ljubljana, Slovenia

View Trial Details

Recruiting

Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma

NCT04903119

Conditions: BRAF Gene Mutation, Melanoma, Metastatic Melanoma, +11 more
Locations: University of Iowa Iowa City, Iowa, United States

Markey Cancer Center Lexington, Kentucky, United States

St. Luke's University Health Network Easton, Pennsylvania, United States

Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Recruiting

A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3

NCT06887348

Conditions: Adenocarcinoma, Advanced Solid Tumor, Carcinoma, +20 more
Locations: UC San Diego Moores Cancer Center La Jolla, California, United States

Tasman Oncology Research Southport, Queensland, Australia

View Trial Details

Recruiting

Mirdametinib in Patients With Advanced NF1-mutant Melanoma

NCT07237100

Conditions: Advanced Unresectable Melanoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +21 more
Locations: California Pacific Medical Center - Sutter Health San Francisco, California, United States

View Trial Details

Recruiting

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

NCT04511013

Conditions: Acral Lentiginous Melanoma, Brain Diseases, Brain Neoplasms, +22 more
Locations: University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Thomas Hospital Fairhope, Alabama, United States

Mobile Infirmary Medical Center Mobile, Alabama, United States

Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States

View all 331 locations

View Trial Details

Recruiting

Ipilumumab and Nivolumab With or Without Hypofractionated Radiotherapy in Patients With Metastatic Melanoma

NCT03646617

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: Lancaster General Hospital Lancaster, Pennsylvania, United States

Abramson Cancer Center Philadelphia, Pennsylvania, United States

Huntsman Cancer Institute at the University of Utah Salt Lake City, Utah, United States

View Trial Details

Recruiting

Interim FDG PET-CT in Melanoma Metastatic Patient's Treated by Anti-PD1 Therapy

NCT03888950

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: CHU de Nice Nice, CHU de NICE, France

View Trial Details

Recruiting

In Vivo Liquid Biopsy of Melanoma (Cytophone)

NCT06488365

Conditions: Circulating Tumor Cells, Diagnosis, Disease, +18 more
Locations: SSM Health Dean Medical Group Specialty Services Madison, Wisconsin, United States

View Trial Details

Recruiting

Precision Radiation of Immune Checkpoint Therapy Resistant Melanoma Metastases

NCT04793737

Conditions: Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations: Division of Head-Neck, Lung and Skin cancers, Theme Cancer, Karolinska University Hospital Stockholm, Sweden

View Trial Details